SOLARA.NS Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: February 24, 2026
Report Source: 2026 3rd Quarter Report
Solara Active Pharma Sciences Ltd. Stock Analysis SOLARA.NS
Solara Active Pharma Sciences Ltd. engages in the manufacture and development of active pharmaceutical ingredient. The company is headquartered in Chennai, Tamil Nadu and currently employs 1,775 full-time employees. The company went IPO on 2018-06-27. The firm is engaged in the manufacturing and development of APIs and offers contract manufacturing and development services for global companies. Its commercial product category includes Albendazole, Aprepitant (Antiemetic), Colchicine, Citicoline Sodium, Disulfiram, Dolutegravir, Etomidate, Flucytosine, Ibuprofen Arginine, Lurasidone Hydrochloride, Rifaximin, Tioconazole, Zileuton and others. Its research and development (R&D) product category includes Brivaracetam, Flecainide Acetate, Naproxen Base, Obeticholic acid, Patiromer Sorbitex Calcium, Rotigotine, Safinamide, Sapropterin, Sugammadex, Tranexamic Acid, Sucroferric Oxyhydroxide and others. Its business is spread across 70 countries with operations in the key markets of North America, Europe, Japan, South Korea and the Middle East and North Africa. The company has one R&D center in Chennai.
Read More Solara Active Pharma Sciences Ltd (SOLARA.NS) Chart
Key Statistics of Solara Active Pharma Sciences Ltd (SOLARA.NS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹514.10Volume
4.01MP/E Ratio (TTM)
4,571.3952 Week Range
Market Cap
24.97BAvg. Volume
113.32KDividend Yield
-Financial Metrics & Statements of Solara Active Pharma Sciences Ltd (SOLARA.NS)
FAQ's for Solara Active Pharma Sciences Ltd (SOLARA.NS)
- According to Musaffa’s Shariah screening methodology, Solara Active Pharma Sciences Ltd (SOLARA.NS) is currently classified as HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.